JCM

Triple Flag Delivers Strong Q4 and Full Year 2023 Results; Long-Term GEOs Outlook Driven by Growth at Northparkes

Retrieved on: 
Wednesday, February 21, 2024

Triple Flag’s long-term GEOs sales outlook builds on the sector-leading growth achieved since our inception, with a compound annual growth rate of more than 20% since 2017.

Key Points: 
  • Triple Flag’s long-term GEOs sales outlook builds on the sector-leading growth achieved since our inception, with a compound annual growth rate of more than 20% since 2017.
  • Northparkes (54% gold stream and 80% silver stream): Sales from Northparkes in Q4 2023 were 3,339 GEOs.
  • Beta Hunt (3.25% gold GRR and 1.5% NSR gold royalty): Royalties from Beta Hunt in Q4 2023 equated to 1,260 GEOs.
  • Camino Rojo (2.0% NSR gold royalty on oxides): Royalties from Camino Rojo in Q4 2023 equated to 680 GEOs.

New Clinical Publication Reports First Three Patients in Early Feasibility Trial for Envoy Medical’s Fully Implanted Cochlear Device

Retrieved on: 
Thursday, October 19, 2023

WHITE BEAR LAKE, Minnesota, Oct. 19, 2023 (GLOBE NEWSWIRE) -- A recent clinical publication in the Journal of Clinical Medicine (JCM) highlighted early surgical experience with Envoy Medical®, Inc.’s (“Envoy Medical”) (NASDAQ: “COCH”) investigational Acclaim® fully implantable cochlear implant. According to the publication, "All three surgeries proceeded without complication, and at activation, all three patients were hearing through their devices. Surgery is more technically challenging compared to a standard cochlear implant, but the skills needed can be mastered by a dedicated otologic surgeon."

Key Points: 
  • According to the publication, "All three surgeries proceeded without complication, and at activation, all three patients were hearing through their devices.
  • The Company currently expects to file for an investigational device exemption (IDE) in early 2024 to commence a pivotal clinical trial later that year.
  • Envoy Medical’s device, the fully implanted Acclaim® cochlear implant seeks to alleviate these limitations by being the first fully implanted cochlear implant (sometimes referred to as a totally implanted cochlear implant or “TICI”).
  • Envoy Medical’s Acclaim® may become the first fully implanted cochlear implant to begin a pivotal trial in the United States.

Cinekid for Professionals presents a comprehensive industry programme, igniting innovation and collaboration

Retrieved on: 
Thursday, October 12, 2023

AMSTERDAM, Oct. 12, 2023 /PRNewswire/ -- Today, Cinekid for Professionals presents its extensive international industry programme. As a crucial part of Cinekid Festival 2023, world's largest media and film festival for children, they welcome over three hundred professionals in the children's film industry annually. The Cinekid for Professionals industry programme starts on October 24, at the main location of Cinekid Festival in Amsterdam Noord. On the agenda are an exclusive view of the project Sam & Julia, a special keynote from the Animation Art Director at Pixar Animation Studios, Deanna Marsigliese, and the celebration of the 10th anniversary of one of the talent development programmes, Cinekid Script LAB.

Key Points: 
  • AMSTERDAM, Oct. 12, 2023 /PRNewswire/ -- Today, Cinekid for Professionals presents its extensive international industry programme.
  • The Cinekid for Professionals industry programme starts on October 24, at the main location of Cinekid Festival in Amsterdam Noord.
  • Heleen Rouw, Director of Cinekid: "At Cinekid Festival, we connect the creators with our young audience in all activities.
  • Cinekid for Professionals (CfP) provides comprehensive year-round industry programming for film professionals, targeting the entire life cycle of a film.

Cinekid for Professionals presents a comprehensive industry programme, igniting innovation and collaboration

Retrieved on: 
Thursday, October 12, 2023

AMSTERDAM, Oct. 12, 2023 /PRNewswire/ -- Today, Cinekid for Professionals presents its extensive international industry programme. As a crucial part of Cinekid Festival 2023, world's largest media and film festival for children, they welcome over three hundred professionals in the children's film industry annually. The Cinekid for Professionals industry programme starts on October 24, at the main location of Cinekid Festival in Amsterdam Noord. On the agenda are an exclusive view of the project Sam & Julia, a special keynote from the Animation Art Director at Pixar Animation Studios, Deanna Marsigliese, and the celebration of the 10th anniversary of one of the talent development programmes, Cinekid Script LAB.

Key Points: 
  • AMSTERDAM, Oct. 12, 2023 /PRNewswire/ -- Today, Cinekid for Professionals presents its extensive international industry programme.
  • The Cinekid for Professionals industry programme starts on October 24, at the main location of Cinekid Festival in Amsterdam Noord.
  • Heleen Rouw, Director of Cinekid: "At Cinekid Festival, we connect the creators with our young audience in all activities.
  • Cinekid for Professionals (CfP) provides comprehensive year-round industry programming for film professionals, targeting the entire life cycle of a film.

GENESIS MEDTECH NAMES INAUGURAL PRESIDENT TO DRIVE COMMERCIAL STRATEGY FOR NORTH AMERICA

Retrieved on: 
Monday, May 15, 2023

SINGAPORE, MAY 15, 2023 /PRNewswire/ -- Genesis MedTech Group (Genesis or Group) is pleased to announce its appointment of Dr. Mark A. Turco (Dr. Turco), M.D., F.A.C.C., as President of Genesis MedTech Intervention, North America and CEO of JC Medical, Inc. Dr. Turco will lead the commercial strategy for the Vascular Interventions and Structural Heart Franchises in North America, catalysing Genesis' mission to bring innovative medical technologies to healthcare practitioners and patients.

Key Points: 
  • SINGAPORE, MAY 15, 2023 /PRNewswire/ -- Genesis MedTech Group (Genesis or Group) is pleased to announce its appointment of Dr. Mark A. Turco (Dr. Turco), M.D., F.A.C.C., as President of Genesis MedTech Intervention, North America and CEO of JC Medical, Inc. Dr. Turco will lead the commercial strategy for the Vascular Interventions and Structural Heart Franchises in North America, catalysing Genesis' mission to bring innovative medical technologies to healthcare practitioners and patients.
  • Prior to joining Genesis MedTech, Dr. Turco was the President and CEO of Cardiac Implants LLC, a clinical-stage medical device start-up with a novel treatment for tricuspid valvular heart disease.
  • We look forward to creating a positive impact on our patients and healthcare in North America."
  • Dr. Turco shared similar sentiments, "I am thrilled to join Genesis MedTech Group in its mission to make high-quality healthcare accessible globally.

Hitachi: Demonstration Operation of Optimized Performance Enabling Network for Volt/Var(Q) (OPENVQ) of Power Transmission Network Commences in Thailand

Retrieved on: 
Wednesday, April 26, 2023

Hitachi, Ltd. (Hitachi), contractor of the project, and the Electricity Generating Authority of Thailand (EGAT) jointly installed optimized performance enabling network for volt/var(Q) (OPENVQ) and commenced its demonstration operation in February 2023.

Key Points: 
  • Hitachi, Ltd. (Hitachi), contractor of the project, and the Electricity Generating Authority of Thailand (EGAT) jointly installed optimized performance enabling network for volt/var(Q) (OPENVQ) and commenced its demonstration operation in February 2023.
  • In this demonstration operation, the OPENVQ system was linked to SCADA used to monitor and control the power system in the regional control center operated by EGAT in northeastern Thailand.
  • And we already confirmed that the loss of power in the transmission network had been curbed and approximately 1,000 tons of CO2 emissions had been reduced by operating those advanced and efficient power systems in the period from February 21st through March 10th.
  • On April 26th, an opening ceremony was held at the head office of EGAT in Nonthaburi attended by all the parties concerned from both countries to celebrate the start of the demonstration operations.

New Zealand's First Chinese Angel Fund Expands to the US

Retrieved on: 
Thursday, July 21, 2022

NEW YORK, July 21, 2022 /PRNewswire/ -- KungHo Fund (www.kungho.com), the US branch of Zino Ventures (www.zino.co.nz), New Zealand's first Chinese angel fund, began operations in June 2022. On July 19, KungHo Fund's soft launch event will be held at VillageOneArt gallery in Chelsea, Manhattan.

Key Points: 
  • NEW YORK, July 21, 2022 /PRNewswire/ -- KungHo Fund ( www.kungho.com ), the US branch of Zino Ventures ( www.zino.co.nz ), New Zealand's first Chinese angel fund, began operations in June 2022.
  • Because the three traditional strengths of American innovation remain strong in the Post-Pandemic era," said Shawn Ke, KungHo Fund COO & Managing Partner.
  • KungHo Fund is an angel fund launched by Chain Reaction Group, a Zino Ventures company.
  • As the first Chinese angel investment fund in New Zealand, Zino Ventures (est.

Excelsior Mining Announces Interim Assay Results from the JCM Infill Drill Program

Retrieved on: 
Wednesday, June 22, 2022

Selection criteria will be focused on rapid, low-cost solutions to demonstrate that the technology is effective in solving the wellfield challenges.

Key Points: 
  • Selection criteria will be focused on rapid, low-cost solutions to demonstrate that the technology is effective in solving the wellfield challenges.
  • Excelsior intends to undertake a more comprehensive evaluation of the oxide and sulfide potential of its mineral resource and mining assets.
  • Mr. Twyerould has verified that the results were accurate from the official assay certificates provided to Excelsior.
  • Except as required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information.

LONGi to supply 400MW of Hi-MO 5 modules for project in Saudi Arabia

Retrieved on: 
Friday, June 10, 2022

The 400MW plant is located in Rabigh Industrial City, in the Kingdom's western Makkah Province, some 150km from Jeddah, and will exclusively deploy LONGi Hi-MO 5(72C) modules.

Key Points: 
  • The 400MW plant is located in Rabigh Industrial City, in the Kingdom's western Makkah Province, some 150km from Jeddah, and will exclusively deploy LONGi Hi-MO 5(72C) modules.
  • The COD is forecast to take place in July 2023 and will be Marubeni's first large-scale solar project in Saudi Arabia and its fourth in the MENA region.
  • Jia Chao, LONGi VP for MEA & CA, concluded: 'Saudi Arabia is at the heart of the Arab and Islamic worlds, leading investment capabilities and sustainable Vision 2030 ambitions.
  • Founded in 2000, LONGi is committed to being the world's leading solar technology company, focusing on customer-driven value creation for full scenario energy transformation.

JCM Global Partners with Cassida Pro on Cash Processing for Gaming Industry

Retrieved on: 
Tuesday, April 19, 2022

Back in the casinos cash room, Cassida Pro Zeus currency discriminators streamline cash processing with leading-edge bill recognition, unsurpassed counterfeit detection and minimalistic machine design.

Key Points: 
  • Back in the casinos cash room, Cassida Pro Zeus currency discriminators streamline cash processing with leading-edge bill recognition, unsurpassed counterfeit detection and minimalistic machine design.
  • For more than 60 years JCM Global has been a leader in payment technologies, and Cassida Pro is proud to partner with them to offer the casino industry our latest advancements in cash processing solutions, said Matthew Holt, director of partnerships and operations for Cassida Pro.
  • The opportunity to create custom programming on the Cassida Pro Zeus to read casino gaming tickets for JCM Global has been mutually beneficial.
  • In 2022, Cassida Pro launched its latest product, the Cassida Pro Split Recycler, the industrys first middle automation cash room solution.